Xamoterol

Xamoterol
Clinical data
ATC code	C01CX07 (WHO)
Identifiers
	IUPAC name (RS)-N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide;
CAS Number	81801-12-9
PubChem (CID)	155774
IUPHAR/BPS	538
ChemSpider	137213
UNII	7HE0JQL703
KEGG	D06328
ChEMBL	CHEMBL75753
Chemical and physical data
Formula	C16H25N3O5
Molar mass	339.387 g/mol
3D model (Jmol)	Interactive image
	SMILES O=C(NCCNCC(O)COc1ccc(O)cc1)N2CCOCC2 ;
	InChI InChI=1S/C16H25N3O5/c20-13-1-3-15(4-2-13)24-12-14(21)11-17-5-6-18-16(22)19-7-9-23-10-8-19/h1-4,14,17,20-21H,5-12H2,(H,18,22) ; Key:DXPOSRCHIDYWHW-UHFFFAOYSA-N ;
(what is this?) (verify)

Xamoterol is a cardiac stimulant. It works by binding to the β₁ adrenergic receptor. It is a 3rd generation adrenergic β receptor partial agonist.^[1] It provides cardiac stimulation at rest but it acts as a blocker during exercise.^[2]

References[edit]

^ Marlow, HF (1989). "Xamoterol, a β₁-adrenoceptor partial agonist: review of the clinical efficacy in heart failure" (PDF). British Journal of Clinical Pharmacology. 28 Suppl 1: 23S–30S. doi:10.1111/j.1365-2125.1989.tb03570.x. PMC 1379873. PMID 2572251. Retrieved 6 March 2016.
^ Rang, H.P.; Dale, M.M.; Ritter, J.M.; Moore, P.K. (1999). Pharmacology (5th ed.). Edinburgh; New York: Churchill Livingstone. p. 163. ISBN 0443059748.

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.